Ng George K

Chief Executive Officer

Ng George K has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 11 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.

On the most recent filing, Ng George K is listed as Chief Executive Officer at Processa Pharmaceuticals, Inc. Inside the rolling window, Ng George K reported 7 open-market purchases totaling $39K in PCSA and no open-market sales. The largest disclosed transaction in the window is a purchase of 3,057 PCSA shares on Jul 1, 2026, worth $6K.

Companies traded

Other insiders at PCSA

Insider Buying

$39K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PCSAPurchase$6KJul 1SEC ↗
PCSAPurchase$5KJun 16SEC ↗
PCSAPurchase$5KJun 1SEC ↗
PCSAPurchase$5KMay 19SEC ↗
PCSAPurchase$5KMay 19SEC ↗
PCSAPurchase$5KMay 1SEC ↗
PCSAPurchase$5KApr 30SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Ng George K made?

Ng George K has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.

Which companies does Ng George K trade?

Ng George K has filed SEC Form 4 disclosures for 1 company, including PCSA.

When was Ng George K's most recent SEC Form 4 filing?

Ng George K's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.

What is Ng George K's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Ng George K is listed as Chief Executive Officer.

What is Ng George K's total buy and sell value in the current window?

Inside the rolling retention window, Ng George K bought $39K and sold $0 based on SEC Form 4 filings.

What was Ng George K's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 3,057 PCSA shares on 2026-07-01, worth $6K, per SEC Form 4 filings.